31.59
2.83%
0.87
Pre-market:
31.30
-0.29
-0.92%
Artivion Inc stock is traded at $31.59, with a volume of 339.24K.
It is up +2.83% in the last 24 hours and up +10.92% over the past month.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.
See More
Previous Close:
$30.72
Open:
$31.11
24h Volume:
339.24K
Relative Volume:
1.32
Market Cap:
$1.32B
Revenue:
$384.90M
Net Income/Loss:
$-851.00K
P/E Ratio:
-1,579.50
EPS:
-0.02
Net Cash Flow:
$12.83M
1W Performance:
+6.44%
1M Performance:
+10.92%
6M Performance:
+16.05%
1Y Performance:
+73.19%
Artivion Inc Stock (AORT) Company Profile
Name
Artivion Inc
Sector
Industry
Phone
(770) 419-3355
Address
1655 ROBERTS BOULEVARD N W, KENNESAW
Compare AORT with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
AORT
Artivion Inc
|
31.59 | 1.32B | 384.90M | -851.00K | 12.83M | -0.02 |
ABT
Abbott Laboratories
|
116.79 | 201.01B | 41.22B | 5.77B | 6.49B | 3.29 |
SYK
Stryker Corp
|
395.85 | 150.90B | 21.97B | 3.59B | 3.21B | 9.33 |
BSX
Boston Scientific Corp
|
100.91 | 148.72B | 15.91B | 1.79B | 1.89B | 1.21 |
MDT
Medtronic Plc
|
88.38 | 113.33B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
69.97 | 41.27B | 6.60B | 4.16B | 490.10M | 6.93 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-23-24 | Initiated | JMP Securities | Mkt Outperform |
Sep-27-22 | Reiterated | Lake Street | Buy |
Aug-08-22 | Initiated | Lake Street | Buy |
Mar-03-22 | Initiated | Stifel | Buy |
Artivion Inc Stock (AORT) Latest News
Artivion, Inc. (NYSE:AORT) Holdings Raised by JPMorgan Chase & Co. - MarketBeat
JPMorgan Chase & Co. Has $2.61 Million Stock Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Is Artivion, Inc. (AORT) Among Billionaire Joseph Edelman’s Long-Term Stock Picks? - MSN
Artivion (NYSE:AORT) Hits New 1-Year HighTime to Buy? - MarketBeat
CryoLife Stock Soars to 52-Week High, Hits $30.62 - Investing.com
GAMMA Investing LLC Purchases 497 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Why Investors Shouldn't Be Surprised By Artivion, Inc.'s (NYSE:AORT) P/S - Simply Wall St
New Strong Buy Stocks for January 7th - MSN
Artivion, Inc. (NYSE:AORT) Shares Sold by Principal Financial Group Inc. - Defense World
Franklin Resources Inc. Boosts Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Geode Capital Management LLC Has $23.46 Million Stock Position in Artivion, Inc. (NYSE:AORT) - Defense World
Jane Street Group LLC Has $1.63 Million Stock Holdings in Artivion, Inc. (NYSE:AORT) - MarketBeat
Barclays PLC Purchases 54,996 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Barclays PLC Has $1.89 Million Stock Position in Artivion, Inc. (NYSE:AORT) - MarketBeat
Jane Street Group LLC Purchases 24,945 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Artivion: Current Valuation Seems Stretched (NYSE:AORT) - Seeking Alpha
Lord Abbett & CO. LLC Invests $5.80 Million in Artivion, Inc. (NYSE:AORT) - MarketBeat
The Manufacturers Life Insurance Company Has $522,000 Stake in Artivion, Inc. (NYSE:AORT) - Defense World
Fmr LLC Has $3.07 Million Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Fmr LLC Buys 25,176 Shares of Artivion, Inc. (NYSE:AORT) - MarketBeat
Tidal Investments LLC Has $4.18 Million Holdings in Artivion, Inc. (NYSE:AORT) - MarketBeat
Wellington Management Group LLP Boosts Holdings in Artivion, Inc. (NYSE:AORT) - MarketBeat
BNP Paribas Financial Markets Boosts Stock Position in Artivion, Inc. (NYSE:AORT) - MarketBeat
Artivion (NYSE:AORT) Earns “Market Outperform” Rating from JMP Securities - Defense World
Artivion says cybersecurity incident has disrupted order, shipping processes - MedTech Dive
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial Results - Kilgore News Herald
In-Depth Examination Of 6 Analyst Recommendations For Artivion - Benzinga
Ransomware disrupts Artivion’s shipping processes - SC Media
Artivion's chief accounting officer Amy Horton sells shares for $128,398 By Investing.com - Investing.com South Africa
Artivion, Inc. Grants FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis - Marketscreener.com
Artivion’s (AORT) “Buy” Rating Reaffirmed at Needham & Company LLC - Defense World
Artivion Cyberattack: Systems Offline, Operations Continue - The Cyber Express
Artivion reports cybersecurity incident, expects no material impact By Investing.com - Investing.com Canada
Artivion Inc. Discloses November 2024 Cyberattack, Raising Concerns of Possible Data Breach - JD Supra
Artivion's chief accounting officer Amy Horton sells shares for $128,398 - Investing.com
US medical device giant Artivion says hackers stole files during cybersecurity incident - MSN
Medical device company says shipping processes disrupted by ransomware attack - The Record from Recorded Future News
Artivion reports cybersecurity incident, expects no material impact - Investing.com
Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis - PR Newswire
Artivion Restoring Systems After Cyberattack - MarketWatch
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 125,668 Shares of Artivion, Inc. (NYSE:AORT) - MarketBeat
FDA grants exemption for new aortic dissection device - Investing.com
Artivion to Participate in Upcoming Investor Conferences - The Eastern Progress Online
Centiva Capital LP Takes Position in Artivion, Inc. (NYSE:AORT) - MarketBeat
Walleye Capital LLC Takes Position in Artivion, Inc. (NYSE:AORT) - MarketBeat
Artivion Inc Stock (AORT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):